GlassScriptPhysician profile
Deryck Fernandez
NPI 1639463086
$580.55
in general payments reported to CMS, 2019-2025
14 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $134 · 2021: $14.59 · 2022: $26.47 · 2023: $19.40 · 2024: $37.10 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $134.38 | 2020 | |
| Cook Medical LLC | $104.48 | 2019 | |
| Novo Nordisk INC | $81.37 | 2021-2025 | |
| Medtronic, INC. | $73.41 | 2025 | Intellis Adaptivestim |
| Philips North America LLC | $26.47 | 2022 | |
| Exact Sciences Corporation | $21.56 | 2025 | Cologuard Collection Kit |
| Djo, LLC | $20.48 | 2025 | Cmf |
| Globus Medical, INC. | $20.28 | 2025 | Senza |
| Glaxosmithkline, LLC. | $19.40 | 2023 | Arexvy, Shingrix |
| Xeris Pharmaceuticals, INC. | $19.25 | 2025 | Recorlev |
| Lilly USA, LLC | $16.37 | 2025 | Zepbound, Mounjaro |
| Paratek Pharmaceuticals, INC. | $14.51 | 2025 | Nuzyra |
| Smith+Nephew, INC. | $14.50 | 2024 | Collagenase Santyl |
| Medtronic Vascular, INC. | $14.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deryck Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.